✦ LIBER ✦

The use of temozolomide in recurrent malignant gliomas

✍ Scribed by A. Gaya; J. Rees; A. Greenstein; J. Stebbing

Book ID: 117817329
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 109 KB
Volume: 28
Category: Article
ISSN: 0305-7372
DOI: 10.1053/ctrv.2002.0261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide in the treatment of recurre

Temozolomide in the treatment of recurrent malignant glioma

✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

Temozolomide + irinotecan active in recu

Temozolomide + irinotecan active in recurrent malignant glioma

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Temozolomide rechallenge in recurrent ma

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule : The “rescue” approach

✍ James R. Perry; Philippe Rizek; Rosemary Cashman; Meredith Morrison; Tara Morris 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Temozolomide beneficial in malignant gli

Temozolomide beneficial in malignant gliomas

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 246 KB

Temozolomide in malignant gliomas: curre

Temozolomide in malignant gliomas: current use and future targets

✍ J. Lee Villano; Tara E. Seery; Linda R. Bressler 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 461 KB

Temozolomide does not increase overall s

Temozolomide does not increase overall survival in recurrent malignant glioma

✍ Roger Stupp 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 81 KB